Jenoptik Ag · XETR:JEN

Jenoptik — 9M 2020 Earnings Presentation

17 slides from Jenoptik's earnings presentation, Nov 10, 2020

  1. Slide 1: JENOPTIK AG – The first nine months 2020

    JENOPTIK AG – The first nine months 2020 Dr. Stefan Traeger I Hans-Dieter Schumacher | November 10, 2020 © Copyright Jenoptik. All rights reserved.

  2. Slide 2: Disclaimer

    Disclaimer This presentation can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the

  3. Slide 3: Agenda

    Agenda Development of the Jenoptik Group Development of the divisions Outlook 10/11/2020 First nine months 2020 3

  4. Slide 4: First nine months 2020: successful acquisition of TRIOPTICS; business development in Q3 improved

    First nine months 2020: successful acquisition of TRIOPTICS; business development in Q3 improved versus prior quarters Revenue  505.0 million euros (prior year 581.4m euros*) EBITDA  Adjusted 73.9 million euros (prior year 92.4m euros) Order intake  510.9 million euros (prior year 558.7m euros*)

  5. Slide 5: Significant growth in order intake in Q3 compared to Q2; book-to-bill higher than in prior year

    Significant growth in order intake in Q3 compared to Q2; book-to-bill higher than in prior year Order intake in million euros Order backlog in million euros 800 800 8.5% +6.9% 600 600 558.7* 510.9 496.7 400 400 464.7* 200 200 0 0 9M/2019 9M/2020 Dec 31, 2019 Sept 30, 2020  Order intake in Q3 with

  6. Slide 6: Revenue improved in Q3 compared with prior quarters; in the entire period decline

    Revenue improved in Q3 compared with prior quarters; in the entire period decline due to pandemic and development in the automotive sector Revenue in million euros  13.1%  Good business with the semiconductor 600 equipment industry and public-sector 581.4* customers continued 500 505.0  Significa

  7. Slide 7: Foreign revenue increased slightly to ~73 percent of total; Americas hit hardest

    Foreign revenue increased slightly to ~73 percent of total; Americas were hit hardest by the pandemic 9M/2020 Middle 22.0 2.2% 9M/2019 East/Africa 21.5* 57.8 Asia/Pacific 15.9% 68.8* 134.5 Americas 21.0% 170.3* 155.3 Europe 2.8% 159.7* 135.5 Germany 15.9% 161.0* *adjusted = here without Hillos 1

  8. Slide 8: Profitability improved in the course of the year

    Profitability improved in the course of the year EBITDA in million euros EBIT in million euros 100  20.0%  32.9% 100 92.4* 80 80 73.9* 60 60 59.1* 40 40 42.6 39.6* 38.1* 20 30.5* 31.7* 20 30.8 23.8 24.9* 26.5* 17.3* 19.7* 20.0* 12.8 6.2* 13.5* 0 0 Q1/19 Q2/19 Q3/19 9M/19 Q4/19 Q1/20 Q2/20 Q3/20 9M

  9. Slide 9: Lower revenue and structural effects affected earnings; EPS remain clearly positive

    Lower revenue as well as effects arising from structural and portfolio measures effected earnings figures; EPS remain clearly positive In million euros 9M/2020 9M/2019 Revenue 505.0 581.4*  Gross margin impacted by higher fixed costs Gross margin 33.4% 35.2% components  Functional costs decreased

  10. Slide 10: Free cash flow improved; sound balance sheet and comfortable liquidity position

    Free cash flow improved; sound balance sheet and comfortable liquidity position in spite of COVID-19 and higher debt due to acquisition of TRIOPTICS  Increase in working capital to 271.1 million euros In million euros 9M/2020 9M/2019 (in particular as a result of acquisitions (31/12/19: 217.8m euro

  11. Slide 11: Agenda

    Agenda Development of the Jenoptik Group Development of the divisions Outlook 10/11/2020 First nine months 2020 11

  12. Slide 12: Light & Optics division: semiconductor equipment business remains robust

    Light & Optics division: business with semiconductor equipment industry remains robust and ensures high margin level  Business with semiconductor equipment industry remained robust, decline in the areas of biophotonics und industrial solutions; TRIOPTICS contributed 0.9 million euros to revenue; pr

  13. Slide 13: Light & Production division: slowdown in automotive capital expenditure and COVID-19

    Light & Production division: slowdown in capital expenditure in automotive industry and COVID-19 impacted business  Revenue in third quarter exceeded figures of prior quarters, but over nine-month period marked decline in all areas; contribution of INTEROB 9.5 million euros  Positive EBITDA in Q3;

  14. Slide 14: Light & Safety division: positive business development; profitability improved

    Light & Safety division: positive business development; profitability noticeably improved  Stable capital spending by public-sector customers; increase in revenue of more than 40% in the Americas and Asia/Pacific  Operating results grew due to higher revenue  Project business leads to fluctuation

  15. Slide 15: VINCORION: Plus in order intake; decrease in revenue and earnings

    VINCORION: Plus in order intake; decrease in revenue and earnings  Revenue lower than in prior year, which was in particular attributable to the decreases in aviation as well as energy & drive, demand in the power systems area remained good  Lower revenue and a lower-margin product mix resulted in

  16. Slide 16: Agenda

    Agenda Development of the Jenoptik Group Development of the divisions Outlook 10/11/2020 First nine months 2020 16

  17. Slide 17: Forecast for fiscal year 2020

    Forecast for fiscal year 2020 The Executive Board anticipates: including the revenue contribution by TRIOPTICS (approx. 25 million euros), revenue in a range of 755 to 775 million euros, and an adjusted* EBITDA margin between 15.0 and 15.5 percent before PPA effects arising from the acquisition of T

Jenoptik — 9M 2020 Earnings Presentation on 6ix